NSF International’s pharmaceutical team is proud to be exhibiting and speaking at the Royal Pharmaceutical Society’s 16^th Joint Qualified Person (QP) Symposium.

To be held on the 16 of May, the event will see NSF pharmaceutical team directors Catherine Kay and Dave Waddington on hand to answer all your QP-related questions.

The event provides a fantastic opportunity for QPs to stay up to date with the latest developments in a changing pharmaceutical world with increasingly complex manufacturing and supply chains. It also provides a great opportunity to network with fellow QPs and discuss the issues you face on a day-to-day basis.

At 14:00pm, NSF’s Dave Waddington will present a 40-minute legislation update session. Individuals from the Medicines and Healthcare products Regulatory Agency (MHRA) will also be speaking at the event, and you will also learn about the latest developments on the safe and effective use of chimeric antigen receptor (CAR) T-cell therapies and advanced therapy medicinal products (ATMP). See the conference website for the full agenda.

Whether you’re a current QP looking to keep up to date and join in with the interactive panel discussions and Q&As, you are considering the move to becoming a QP, or you have a particular interest in the industry, visit NSF at its stand and speak to NSF International’s QP team.

NSF looks forward to seeing you on the 16 May at the 16^th Joint QP Symposium.

Book your place today and contact NSF using the contact form if you have questions.